author-photo

G Hantsbarger

Takeda Pharmaceutical Company

9

Papers

11

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

P527 Investigating fatigue in vedolizumab-treated patients with ulcerative colitis or Crohn’s disease from a Belgian registry

2021 Journal of Crohn's and Colitis
Show All
- Source
- Cite
- Save
Citations (0)
DOP57 Predictive modelling to examine long term treatment effectiveness of darvadstrocel in patients with complex perianal fistulas in Crohn’s Disease

2021 Journal of Crohn's and Colitis
Show All
- Source
- Cite
- Save
Citations (0)
Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post‐marketing data

2019 Alimentary Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (8)
P724 Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data

2019 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (0)
DOP005 Safety of vedolizumab in patients naïve to treatment with TNF antagonists compared with patients with prior use of TNF antagonists

2018 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (1)